General Information of the Compound
| Compound ID |
CP0904979
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(2,6-difluorophenyl)-3-(3-{2-[(5-methyl-2-(methyloxy)-4-{4-[2-(methyloxy)ethyl]-1-piperazinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C39H38F2N8O3
|
||||||||||||||||||
| Molecular Weight |
704.782
|
||||||||||||||||||
| Canonical SMILES |
COCCN1CCN(c2cc(OC)c(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6c(F)cccc6F)c5)nc5ccccn45)n3)cc2C)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C39H38F2N8O3/c1-25-22-31(33(52-3)24-32(25)48-18-16-47(17-19-48)20-21-51-2)44-39-42-14-13-30(43-39)37-35(45-34-12-4-5-15-49(34)37)26-8-6-9-27(23-26)38(50)46-36-28(40)10-7-11-29(36)41/h4-15,22-24H,16-21H2,1-3H3,(H,46,50)(H,42,43,44)
Show/Hide
|
||||||||||||||||||
| InChIKey |
HZLOBVCRFFOUIV-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01101, Insulin receptor
Protein ID: PT01104, Insulin-like growth factor 1 receptor